Protein / target
Glycine receptor subunit beta
Protein at a glance
Biological role
Glycine-gated chloride channel activity
Primary system
Nervous system
Strongest disease association
hyperekplexia 2
Therapeutic maturity
Clinically validated target
Druggability
Small molecule
Clinical development
6 approved
Derived from structured UniProt, Open Targets and literature data on this page.
Protein profile
Canonical identity and biological annotation from UniProt.
Function
Subunit of heteromeric glycine-gated chloride channels (PubMed:11929858, PubMed:15302677, PubMed:16144831, PubMed:22715885, PubMed:23238346, PubMed:25445488, PubMed:34473954, PubMed:8717357). Plays an important role in the down-regulation of neuronal excitability (PubMed:11929858, PubMed:23238346). Contributes to the generation of inhibitory postsynaptic currents (PubMed:25445488)
Subcellular location
Domains and Gene Ontology detail (22)Hide
Gene Ontology
- Ccytoplasm
- Cdendrite
- CGABA-ergic synapse
- Cglycine-gated chloride channel complex
- Cglycinergic synapse
- Cplasma membrane
- Cpostsynaptic membrane
- Cpostsynaptic specialization
- Fexcitatory extracellular ligand-gated monoatomic ion channel activity
- Fextracellularly glycine-gated chloride channel activity
- Fextracellularly glycine-gated ion channel activity
- Fglycine binding
Biological roles
What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.
View supporting evidenceHide supporting evidence
Synaptic signalling
- ·Subunit of heteromeric glycine-gated chloride channels (PubMed:11929858, PubMed:15302677…
- ·Postsynaptic cell membrane
- ·Synapse
- ·GABA-ergic synapse
Inhibitory neurotransmission
- ·Subunit of heteromeric glycine-gated chloride channels (PubMed:11929858, PubMed:15302677…
- ·GABA-ergic synapse
- ·glycinergic synapse
- ·synaptic transmission, glycinergic
Chloride transport
- ·Subunit of heteromeric glycine-gated chloride channels (PubMed:11929858, PubMed:15302677…
- ·glycine-gated chloride channel complex
- ·extracellularly glycine-gated chloride channel activity
Ion channel gating
- ·excitatory extracellular ligand-gated monoatomic ion channel activity
- ·extracellularly glycine-gated ion channel activity
- ·transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic…
Ligand-gated signalling
- ·excitatory extracellular ligand-gated monoatomic ion channel activity
- ·extracellularly glycine-gated ion channel activity
- ·transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic…
Motor control
- ·startle response
View underlying pathways (1)Hide underlying pathways
Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.
Interaction neighbourhood
Proteins with the strongest functional or physical association. Node size and line weight reflect STRING confidence; hover or select a partner to inspect one association.
Functional and physical associations from STRING v12.0. Only associations with this protein are drawn — partner-to-partner links are not part of this evidence.
Drugs targeting this protein
Whether each drug engages this protein directly or through a complex, and how many other targets are recorded for it. Direct binders with few recorded targets are listed first.
Glycine receptor (alpha-1/beta) positive modulator
Appears in clinical studies involving kidney injury, Hydrocephalus, delirium, sedation
Glycine receptor (alpha-1/beta) positive modulator
Appears in clinical studies involving septic shock, Sepsis
Glycine receptor (alpha-1/beta) positive modulator
Appears in clinical studies involving endometrial cancer, myocardial infarction, sedation, delirium
ChEMBL mechanism, action type and target identity. Open Targets clinical status and indications.
Translational evidence
Why this target matters therapeutically — disease associations, drugs in development, tractability and safety, from Open Targets.
Strongest genetic associations
Human genetic evidence — the most direct causal link between this target and a disease.
Highest-confidence therapeutic associations
Diseases where a drug acting on this target has already reached clinical development.
Highest overall evidence
Remaining associations by Open Targets' aggregated evidence score.
Show all associationsHide all associations
Open Targets ranks 2,082 associations for this target and we store the top 10 by aggregated score. The long tail is largely literature co-mention and RNA-expression evidence, not evidence that this target drives those diseases.
Known drugs · 6 total
septic shock · Sepsis
kidney injury · Hydrocephalus · delirium
Fever · Pain · Pain
septic shock · Sepsis
endometrial cancer · myocardial infarction · sedation
Intellectual disability · cognitive disorder · delirium
Tractability
Clinical trials
Trials of drugs that target this protein — reached indirectly through those drugs, so a trial listed here studies the drug, not the protein.
Show remaining trials (24)Hide
ClinicalTrials.gov via the drug-target graph.
Forefront confidence
Our own weighting of the evidence behind each disease association. Human genetics and clinical evidence count for most; literature co-mention counts for little, because two entities sharing an abstract is not evidence that one drives the other.
This ranking differs from Open Targets' own: re-weighting moves genetically-evidenced diseases above more heavily co-mentioned ones. The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the underlying per-type scores are shown above so the calculation can be checked.
What's happening now
Recent activity around this target, drawn from one canonical event stream. Every item is reached through 3 drugs that target this protein, so each event is news about that drug rather than about the protein directly.
- New publicationNeonatal sevoflurane exposures inhibits DHHC5-mediated palmitoylation of TfR1 in oligodendrocytes, leading to hypomyelination and neurological impairments.
- New publicationEarly exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
- New publicationSharp wave-associated high-frequency oscillation (200 Hz) in the intact hippocampus: network and intracellular mechanisms.
Objective event titles are shown unmodified; the event kind and significance line are derived from structured fields. Forefront AttentionEvent stream aggregating Europe PMC Regulatory filings ClinicalTrials.gov.